Drug Delivery Devices Market Size is Estimated to grow at a CAGR of 9.82% during the forecast period
The drug delivery devices market was
estimated to be worth USD 281.9 billion in 2023 and is expected to grow at a
compound annual growth rate (CAGR) of 9.82% from 2024 to 2034, when it is
expected to reach USD 463.1 billion. The goal of drug delivery systems is to
enhance the safety and effectiveness of therapeutic interventions by bringing
pharmacology and engineering together in a crucial way. The market is
increasing and sustainable since it is in line with the healthcare industry.
Drug delivery devices are specialized instruments intended
to administer therapeutic compounds to the body under strict control. These
tools are designed to maximize drug release and absorption, guaranteeing that
the right dosage is delivered precisely and effectively to the intended side.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/drug-delivery-devices-market
GROWTH DRIVERS
The usefulness and effectiveness of drug delivery systems
have been greatly improved by technological developments in the fields of
material science, biotechnology, and microelectronics. The precise
targeting-controlled release and improved patient compliance made possible by
these advances are key factors in the market's uptake and expansion. The
National Institutes of Health (NIH) states that newer drug delivery systems
(DDS) are designed using cutting-edge technology to maximize treatment efficacy
and reduce off-target accumulation in the body by speeding systemic drug
delivery to the precise target site.
The need for efficient medication delivery systems has
increased due to the rise in the incidence of chronic diseases like diabetes,
cancer, and respiratory ailments. The World Health Organization (WHO) estimates
that over 80% of premature deaths globally are caused by chronic diseases
(NCDs), which include diabetes, cancer, and chronic respiratory illnesses. 86%
of fatalities before the age of 70 are caused by these diseases, accounting for
74% of all deaths worldwide. In the United States, diabetes was the cause of
nearly 103,000 fatalities in 2021.
The World Health Organization (WHO) projects that there
will be 1.4 billion adults 60 and older by 2030 and 2.1 billion by 2050, up
from 1 billion in 2019. According to UN estimates, the proportion of the
population 65 and older will rise from 10% in 2022 to 16% in 2050. The FDA and
EMA, among other regulatory organizations, are increasingly approving innovative
delivery devices due to favorable regulatory requirements, which facilitates
their entry into the market and fosters innovation.
MARKET
SEGMENTATION:
· By
Route of Administration- oral, inhalation, transdermal, injectable,
ocular, nasal, topical and others
· By
Application- cancer, diabetes, respiratory diseases, cardiovascular
diseases, infectious diseases, central nervous system disorders, pain
management and others
· By
Distribution Channel- Direct sales, online sales, distribution and retail
· By
End-User- hospitals, clinics, diagnostic center and home care settings
· By
Region- North America, Europe, Asia Pacific, Middle East and Africa,
South America
Global Key
Players:
· Pfizer
· Johnson
& Johnson Services
· F.
Hoffmann-La Roche
· Novartis
· Baxter
· Bayer
AG
· Uniqure
NV
· Becton
Dickson & Company
· Sibiono
Genetech Co.
· Medtronic
· Nemrara
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/drug-delivery-devices-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment